Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Chlorine substituents and linker topology as factors of 5-HT6R activity for novel highly active 1,3,5-triazine derivatives with procognitive properties in vivo
Sylwia Sudoł, Katarzyna Kucwaj‐Brysz, Rafał Kurczab, et al.
European Journal of Medicinal Chemistry (2020) Vol. 203, pp. 112529-112529
Open Access | Times Cited: 19

Showing 19 citing articles:

First-in-Class Selenium-Containing Potent Serotonin Receptor 5-HT6 Agents with a Beneficial Neuroprotective Profile against Alzheimer’s Disease
Patryk Pyka, Wawrzyniec Haberek, Małgorzata Więcek, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 2, pp. 1580-1610
Open Access | Times Cited: 12
Selenium-containing compounds: a new hope for innovative treatments in Alzheimer’s disease and Parkinson’s disease
Patryk Pyka, Sabrina Garbo, Rossella Fioravanti, et al.
Drug Discovery Today (2024) Vol. 29, Iss. 8, pp. 104062-104062
Open Access | Times Cited: 7
Chemical update on the potential for serotonin 5-HT6 and 5-HT7 receptor agents in the treatment of Alzheimer’s disease
Katarzyna Kucwaj‐Brysz, Hanna Baltrukevich, Kinga Czarnota, et al.
Bioorganic & Medicinal Chemistry Letters (2021) Vol. 49, pp. 128275-128275
Open Access | Times Cited: 35
Procognitive Potential of Neuroprotective Triazine 5-HT6 Receptor Antagonists Tested on Chronic Activity In Vivo in Rats: Computer-Aided Insight into the Role of Chalcogen-Differences on the Pharmacological Profile
Magdalena Jastrzębska‐Więsek, Sabrina Garbo, Agnieszka Cios, et al.
ACS Chemical Neuroscience (2025)
Open Access
Synthesis, computational and experimental pharmacological studies for (thio)ether-triazine 5-HT6R ligands with noticeable action on AChE/BChE and chalcogen-dependent intrinsic activity in search for new class of drugs against Alzheimer's disease
Kinga Czarnota-Łydka, Sylwia Sudoł-Tałaj, Katarzyna Kucwaj‐Brysz, et al.
European Journal of Medicinal Chemistry (2023) Vol. 259, pp. 115695-115695
Open Access | Times Cited: 10
Green synthesis of 1,3,5-triazine derivatives using a sonochemical protocol
Damian Kułaga, Anna K. Drabczyk, Przemysław Zaręba, et al.
Ultrasonics Sonochemistry (2024) Vol. 108, pp. 106951-106951
Open Access | Times Cited: 3
Seleno-vs. thioether triazine derivatives in search for new anticancer agents overcoming multidrug resistance in lymphoma
Wesam Ali, Sabrina Garbo, Annamária Kincses, et al.
European Journal of Medicinal Chemistry (2022) Vol. 243, pp. 114761-114761
Closed Access | Times Cited: 15
A closer look at N2,6-substituted 1,3,5-triazine-2,4-diamines: Advances in synthesis and biological activities
Muhammad Syafiq Bin Shahari, Anton V. Dolzhenko
European Journal of Medicinal Chemistry (2022) Vol. 241, pp. 114645-114645
Closed Access | Times Cited: 13
An exit beyond the pharmacophore model for 5-HT6R agents - a new strategy to gain dual 5-HT6/5-HT2A action for triazine derivatives with procognitive potential
Katarzyna Kucwaj‐Brysz, Wesam Ali, Rafał Kurczab, et al.
Bioorganic Chemistry (2022) Vol. 121, pp. 105695-105695
Closed Access | Times Cited: 11
2-Phenyl-1H-pyrrole-3-carboxamide as a New Scaffold for Developing 5-HT6 Receptor Inverse Agonists with Cognition-Enhancing Activity
Marcin Drop, Vittorio Canale, Séverine Chaumont‐Dubel, et al.
ACS Chemical Neuroscience (2021) Vol. 12, Iss. 7, pp. 1228-1240
Open Access | Times Cited: 12
The Phenoxyalkyltriazine Antagonists for 5-HT6 Receptor with Promising Procognitive and Pharmacokinetic Properties In Vivo in Search for a Novel Therapeutic Approach to Dementia Diseases
Sylwia Sudoł, Agnieszka Cios, Magdalena Jastrzębska‐Więsek, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 19, pp. 10773-10773
Open Access | Times Cited: 12
Halogen Bonding Hot Spots as a Constraint in Virtual Screening: A Case Study of 5-HT7R
Rafał Kurczab
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 16, pp. 14007-14015
Closed Access | Times Cited: 1
Design of novel photosensitizers and controlled singlet oxygen generation for photodynamic therapy
Esra Tanrıverdi Eçik, Onur Bulut, Hasan Hüseyin Kazan, et al.
New Journal of Chemistry (2021) Vol. 45, Iss. 35, pp. 16298-16305
Closed Access | Times Cited: 8
New Triazine Derivatives as Serotonin 5-HT6 Receptor Ligands
Dorota Łażewska, Małgorzata Więcek, Grzegorz Satała, et al.
Molecules (2023) Vol. 28, Iss. 3, pp. 1108-1108
Open Access | Times Cited: 3
Multitargeting the Action of 5-HT6 Serotonin Receptor Ligands by Additional Modulation of Kinases in the Search for a New Therapy for Alzheimer’s Disease: Can It Work from a Molecular Point of View?
Kinga Czarnota-Łydka, Katarzyna Kucwaj‐Brysz, Patryk Pyka, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 15, pp. 8768-8768
Open Access | Times Cited: 5
Triazines, Tetrazines, and Fused Ring Polyaza Systems
Marie‐Aude Hiebel, Franck Suzenet
Progress in heterocyclic chemistry (2019), pp. 505-531
Closed Access | Times Cited: 7
Hydrophobicity modulation via the substituents at positions 2 and 4 of 1,3,5-triazine to enhance therapeutic ability against Alzheimer's disease for potent serotonin 5-HT6R agents
Sylwia Sudoł-Tałaj, Katarzyna Kucwaj‐Brysz, Sabina Podlewska, et al.
European Journal of Medicinal Chemistry (2023) Vol. 260, pp. 115756-115756
Open Access | Times Cited: 1
Triazines, tetrazines, and fused ring polyaza systems
Marie‐Aude Hiebel, Franck Suzenet
Progress in heterocyclic chemistry (2021), pp. 441-472
Closed Access | Times Cited: 3
The Therapeutic Potential of 2-{[4-(2-methoxyphenyl)piperazin-1-yl]alkyl}-1H-benzo[d]imidazoles as Ligands for Alpha1-Adrenergic Receptor - Comparative In Silico and In Vitro Study
Jelena Z. Penjišević, Vladimir B. Šukalović, Deana Andrić, et al.
Applied Biochemistry and Biotechnology (2022) Vol. 194, Iss. 8, pp. 3749-3764
Closed Access | Times Cited: 1
Page 1

Scroll to top